Welcome to our dedicated page for Flexible Solutn news (Ticker: FSI), a resource for investors and traders seeking the latest updates and insights on Flexible Solutn stock.
Flexible Solutions International, Inc. reports developments in specialty chemicals, biodegradable polymers, and water and energy conservation technologies. The company’s NanoChem Solutions Inc. subsidiary produces water-soluble products based on thermal polyaspartate biopolymers for uses including oil extraction, detergent ingredients, water treatment, scale inhibition, and crop enhancement.
FSI news commonly covers revenue releases, annual and quarterly financial results, conference-call updates, production activity, and facility changes tied to its Illinois food-grade operations and Panama agriculture and industrial products factory. Company updates also address crop nutrient availability chemistry, food and nutrition supplement manufacturing, and water-conservation products for drinking water, agriculture, industrial markets, and swimming pools.
Flexible Solutions International (FSI), a developer of biodegradable polymers and environmental technologies, has reported its Q4 and full-year 2024 revenue figures. The company experienced a 3% year-over-year decline in Q4 revenue, dropping from $9.43 million in Q4 2023 to $9.15 million in Q4 2024. Full-year revenue showed minimal change, slightly decreasing from $38.3 million in 2022 to $38.2 million in 2023.
CEO Dan O'Brien attributed Q4 weakness to international agriculture market conditions but expressed optimism for improvement in 2025. Complete financial results will be released after market close on March 31, 2025, followed by a conference call on April 1, 2025.
Flexible Solutions International (FSI) reported strong Q3 2024 financial results with sales of $9.3 million, up 7% from $8.7 million in Q3 2023. Net income reached $611,858 ($0.05 per share) compared to a net loss of $(718,161) ($(0.06) per share) in Q3 2023. The company's 9-month operating cash flow improved to $5.9 million ($0.47 per share) from $3.3 million ($0.26 per share) in 2023. The NanoChem division and ENP subsidiary remain the main revenue drivers, with new opportunities emerging in food products, detergent, water treatment, and agricultural sectors.
Flexible Solutions International, Inc. (NYSE-AMERICAN: FSI), a developer and manufacturer of biodegradable polymers and environmentally friendly technologies, has announced its Q3 2024 revenue. The company reported a 6.5% year-over-year increase in top-line revenue, rising from $8.721 million in Q3 2023 to $9.287 million in Q3 2024.
FSI specializes in products for oil extraction, detergent ingredients, water treatment, crop nutrient availability, nutraceuticals, and water and energy conservation. The complete financial results will be available after market close on November 14, 2024, coinciding with the company's SEC filings. A conference call is scheduled for November 15, 2024, at 8:00 am Pacific Time (11:00 am Eastern Standard Time) to discuss the results.
Flexible Solutions International (NYSE Amex: FSI) reported its Q2 2024 financial results, showing improvement over the previous year. Key highlights include:
- Q2 sales increased by 2% to $10,528,739 compared to $10,331,291 in Q2 2023
- Net income rose to $1,289,796 ($0.10 per share) from $809,865 ($0.07 per share) in Q2 2023
- 6-month operating cash flow improved to $3,853,907 ($0.31 per share) from $3,220,674 ($0.26 per share) in the same period of 2023
The NanoChem division and ENP subsidiary remain the primary revenue and cash flow generators. The company is exploring new opportunities in various sectors to further increase sales.
Flexible Solutions International (NYSE-AMERICAN: FSI) has announced the sale of units in its Florida investment for a total of $6 million, to be paid over five years. The original purchase price was $3.5 million. This transaction is expected to increase FSI's liquidity and support potential growth in its nutrition and food operations.
CEO Dan O'Brien stated that the sale will contribute to FSI's ability to take on significant contracts in the coming months. The new partner in the Florida is expected to expand sales, which could benefit FSI through a retained supply agreement. Increased sales to the Florida are anticipated to begin in the next several quarters.
Flexible Solutions International (NYSE-AMERICAN: FSI), a developer and manufacturer of biodegradable polymers and environmentally safe technologies, has announced its Q2 2024 revenue. The company reported a slight increase in sales, with top-line revenue rising from $10.331 million in Q2 2023 to $10.528 million in Q2 2024, representing a 2% year-over-year growth.
Complete financial results will be released on August 14, 2024, after market close, coinciding with the company's SEC second quarter filings. A conference call is scheduled for August 15, 2024, at 8:00 am Pacific Time (11:00 am Eastern Standard Time) to discuss the results.
Flexible Solutions International (NYSE-AMERICAN: FSI) announced a significant capital expenditure to acquire a production line for vial filling of injectable drugs such as GLP1 for weight loss. The $2.5 million investment secures a nearly-unused production line capable of producing 22.5 million vials per year, reducing the typical wait time and cost for such equipment. The company aims to leverage its existing clean room skills from its food/nutrition division to enter the high-risk, high-reward drug compounding market. CEO Dan O’Brien emphasized the need for de-risking this venture by securing sales and potentially partnering with experienced players in the industry. The company plans to proceed only if the benefits to shareholders outweigh the risks, with a minimum one-year timeframe before production can commence, subject to regulatory approvals.
Flexible Solutions International (FSI) has released its financial results for Q1 2024. The company reported sales of $9.22 million, a decrease of 6% from the $9.85 million in Q1 2023.
Net income fell to $457,226 ($0.04 per share) from $884,369 ($0.07 per share) in the previous year, due to higher costs and one-time expenses related to the closure of its Naperville R&D facility.
Operating cash flow for Q1 2024 was $1.34 million ($0.11 per share), down from $1.73 million ($0.14 per share) in Q1 2023. CEO Daniel B. O’Brien highlighted the progress in operational streamlining and new opportunities in the food and nutraceutical markets expected to drive revenue in 2024.
A conference call is scheduled for May 16, 2024, at 11:00 AM Eastern Time.
Summary not available.
Summary not available.